Cargando…

Construction of a Novel Magnetic Targeting Anti-Tumor Drug Delivery System: Cytosine Arabinoside-Loaded Bacterial Magnetosome

To ease the side effects triggered by cytosine arabinoside (Ara-C) for acute leukemia treatment, a novel magnetic targeting anti-tumor drug delivery system was constructed through bacterial magnetosomes (BMs) from Magnetospirillum magneticum AMB-1 combined with Ara-C by crosslinking of genipin (GP)....

Descripción completa

Detalles Bibliográficos
Autores principales:	Deng, Qiongjia, Liu, Yuangang, Wang, Shibin, Xie, Maobin, Wu, Shenjian, Chen, Aizheng, Wu, Wenguo
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2013
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5452655/ https://www.ncbi.nlm.nih.gov/pubmed/28788304 http://dx.doi.org/10.3390/ma6093755

Ejemplares similares

Preparation and in vitro antitumor effects of cytosine arabinoside-loaded genipin-poly-l-glutamic acid-modified bacterial magnetosomes
por: Liu, Yuan-Gang, et al.
Publicado: (2015)

A radioimmunoassay for cytosine arabinoside.
por: Piall, E. M., et al.
Publicado: (1979)

Bacterial magnetosomes as an efficient gene delivery platform for cancer theranostics
por: Dai, Qinglei, et al.
Publicado: (2017)

Biomedical applications of magnetosomes: State of the art and perspectives
por: Ren, Gang, et al.
Publicado: (2023)

Enhancement of the Cytotoxicity of Cytosine Arabinoside by Interleukin‐3
por: Tanaka, Masao
Publicado: (1992)

High-dose cytosine arabinoside (Ara-C) in colorectal cancer.
por: Kanojia, M., et al.
Publicado: (1983)

Synergistic killing of human leukaemic lymphoblasts by glucocorticoids and cytosine arabinoside.
por: Gledhill, R. M., et al.
Publicado: (1983)

Sensitivity of normal and acute myelogenous leukaemia marrow cells to inhibition by cytosine arabinoside.
por: Potter, C. G., et al.
Publicado: (1980)

High dose cytosine arabinoside in the initial treatment of adults with acute lymphoblastic leukaemia.
por: Rohatiner, A. Z., et al.
Publicado: (1990)

Clinical trial of low dose cytosine arabinoside in the treatment of acute promyelocytic leukemia.
por: Sung, K. W., et al.
Publicado: (1997)

Effect of cytosine arabinoside on cerebellar neurofilaments during development: A sexual dimorphism
por: Koros, Christos, et al.
Publicado: (2014)

Aprepitant Sensitizes Acute Myeloid Leukemia Cells to the Cytotoxic Effects of Cytosine Arabinoside in vitro and in vivo
por: Wu, Hongzhang, et al.
Publicado: (2020)

Combination chemotherapy for choroidal melanoma: ex vivo sensitivity to treosulfan with gemcitabine or Cytosine arabinoside
por: Neale, M H, et al.
Publicado: (1999)

Clofarabine and high-dose cytosine arabinoside in the treatment of refractory or relapsed acute myeloid leukaemia
por: Tse, Eric, et al.
Publicado: (2011)

Evaluating the use of cytosine arabinoside for treatment for recurrent canine steroid-responsive meningitis-arteritis
por: Günther, Christian, et al.
Publicado: (2020)

Interaction of 6-thioguanine and cytosine arabinoside in cultured cells from patients with acute myeloid leukaemia.
por: Robins, A. B.
Publicado: (1978)

Signature-Based Small Molecule Screening Identifies Cytosine Arabinoside as an EWS/FLI Modulator in Ewing Sarcoma
por: Stegmaier, Kimberly, et al.
Publicado: (2007)

Proceedings: Effects of daunomycin, bleomycin, cytosine arabinoside, acronycine and ionizing radiation on the cell cycle in vitro and in vivo.
por: Linden, W. A., et al.
Publicado: (1975)

Micronucleated Erythrocytes in Peripheral Blood from Neonate Rats Exposed by Breastfeeding to Cyclophosphamide, Colchicine, or Cytosine-Arabinoside
por: Gómez-Meda, Belinda C., et al.
Publicado: (2016)

Cytosine Arabinoside and Mitoxantrone Followed by Second Allogeneic Transplant for the Treatment of Children With Refractory Juvenile Myelomonocytic Leukemia
por: Patel, Sachit A., et al.
Publicado: (2014)

Toxicity associated with high-dose cytosine arabinoside and total body irradiation as conditioning for allogeneic bone marrow transplantation
por: Kumar, M, et al.
Publicado: (1997)

The diagnostic dilemma of idiopathic intracranial hypertension in a child with acute lymphoblastic leukemia: COVID-19 or cytosine arabinoside?
por: Rakez, Rim, et al.
Publicado: (2022)

A Natural Bacterium-Produced Membrane-Bound Nanocarrier for Drug Combination Therapy
por: Long, Ruimin, et al.
Publicado: (2016)

Application of Magnetosomes in Magnetic Hyperthermia
por: Usov, Nikolai A., et al.
Publicado: (2020)

Bacterial magnetosomes-based nanocarriers for co-delivery of cancer therapeutics in vitro
por: Long, Rui-Min, et al.
Publicado: (2018)

High-dose cytosine arabinoside plus etoposide as initial treatment for acute myeloid leukaemia: a single centre study.
por: Parikh, P., et al.
Publicado: (1990)

Human tumour xenografts established and serially transplanted in mice immunologically deprived by thymectomy, cytosine arabinoside and whole-body irradiation.
por: Selby, P. J., et al.
Publicado: (1980)

Effects of cytosine arabinoside on differential gene expression in embryonic neural retina. II. Immunochemical studies on the accumulation of glutamine synthetase
Publicado: (1977)

Bacterial magnetosomes loaded with doxorubicin and transferrin improve targeted therapy of hepatocellular carcinoma
por: Wang, Jiaojiao, et al.
Publicado: (2019)

Magnetic Properties of Bacterial Magnetosomes Produced by Magnetospirillum caucaseum SO-1
por: Gareev, Kamil G., et al.
Publicado: (2021)

EFFECTS OF CYTOSINE ARABINOSIDE ON DIFFERENTIAL GENE EXPRESSION IN EMBRYONIC NEURAL RETINA : I. Accumulation of Glutamine Synthetase with Suppression of Macromolecular Synthesis
por: Jones, R. E., et al.
Publicado: (1974)

Prevention of High-Dose Cytosine Arabinoside-Induced Acute Pericarditis with Preemptive Dexamethasone Administration: A Case Report and Literature Review
por: Owattanapanich, Weerapat, et al.
Publicado: (2018)

Low frequency of pre-treatment and post-treatment haematological abnormalities in dogs with non-infectious meningoencephalitis treated with cytosine arabinoside and prednisolone
por: Keegan, Sarah, et al.
Publicado: (2019)

Intravesical mitomycin C (MMC) and MMC + cytosine arabinoside for non‐muscle‐invasive bladder cancer: a randomised clinical trial
por: Miyata, Yasuyoshi, et al.
Publicado: (2021)

The magnetosome model: insights into the mechanisms of bacterial biomineralization
por: Rahn-Lee, Lilah, et al.
Publicado: (2013)

The combination of methotrexate and cytosine arabinoside in newly diagnosed adult Langerhans cell histiocytosis: a prospective phase II interventional clinical trial
por: Han, Xiao, et al.
Publicado: (2020)

Assessment of drug sensitivity of human leukaemic myeloblasts. II. The toxic effects of cytosine arabinoside on 125IUdR-labelled human leukaemic myeloblasts in mice.
por: Sonis, S. T., et al.
Publicado: (1977)

Enhancement of Cytosine Arabinoside Cytotoxicity by Granulocyte/Macrophage Colony‐stimulating Factor and Granulocyte Colony‐stimulating Factor in a Human Myeloblastic Leukemia Cell Line
por: Takauji, Rumiko, et al.
Publicado: (1993)

Iron Oxide Nanoparticles Combined with Cytosine Arabinoside Show Anti-Leukemia Stem Cell Effects on Acute Myeloid Leukemia by Regulating Reactive Oxygen Species
por: Dou, Jun, et al.
Publicado: (2021)

Tuning of Magnetic Hyperthermia Response in the Systems Containing Magnetosomes
por: Molcan, Matus, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_g23enk1fnfeccm0goo9idcferg